 China Biologic Products NASDAQ:CBPO was downgraded by analysts at ValuEngine from a hold rating to a sell rating in a report issued on Tuesday, ValuEngine reports. Several other equities research analysts also recently issued reports on CBPO. BidaskClub downgraded China Biologic Products from a sell rating to a strong sell rating in a report on ... 